After co-injection of AgNO3 (inflammation inducer) and AA fibrils (seed), we showed a significant effect of ApoA-II on elevation of serum SAA levels and AA amyloidosis (Figs 1, 2, 3 and 5). The gene discussed is SAA2; the disease is AA amyloidosis.